Cervical Cancer Diagnostic Tests (Pap Smear, Colposcopy and ECC Procedures) Market is Expected to Reach USD 75.2 Million Globally in 2018: Transparency Market Research
3 Pages
English
Downloading requires you to have access to the YouScribe library
Learn all about the services we offer

Cervical Cancer Diagnostic Tests (Pap Smear, Colposcopy and ECC Procedures) Market is Expected to Reach USD 75.2 Million Globally in 2018: Transparency Market Research

Downloading requires you to have access to the YouScribe library
Learn all about the services we offer
3 Pages
English

Description

Cervical Cancer Diagnostic Tests (Pap Smear, Colposcopy and ECC Procedures) Market is Expected to Reach USD 75.2 Million Globally in 2018: Transparency Market Research PR Newswire ALBANY, New York, October 26, 2012 ALBANY, New York, October 26, 2012 /PRNewswire/ -- According to a new market report published by Transparency Market Research (http://www.transparencymarketresearch.com), "Cervical Cancer Diagnostic Tests (Pap Smear, Colposcopy and ECC Procedures) Market - Global Industry Analysis by Test Type and Age Group, Market Size, Share and Forecast, 2012 - 2018," the global Pap smear test market was valued at USD 28.0 million in 2011 and is expected to reach an estimated value of USD 31.4 million in 2018, growing at a CAGR of 1.7% from 2012 to 2018. The global edocervical curettage (ECC) procedures market was valued at USD 6.7 million in 2011 and is the fastest growing segment owing to its accuracy during cervical cancer diagnosis. Browse the full report at http://www.transparencymarketresearch.com/cervical-cancer-diagnostic-tests- market.html A high prevalence of HPV-infected patients across the globe, rising incidences of teenage sexual encounters, a rising number of organized cervical cancer programs initiated by governments and NGOs and the rising disposable income of consumers especially in the Asia Pacific region are some of the major growth drivers for the Pap smear tests market.

Subjects

Informations

Published by
Reads 13
Language English

Exrait

Cervical Cancer Diagnostic Tests (Pap Smear, Colposcopy and ECC Procedures) Market is Expected to Reach USD 75.2 Million Globally in 2018: Transparency Market Research
PR Newswire ALBANY, New York, October 26, 2012
ALBANY, New York,October 26, 2012/PRNewswire/ --
According to a new market report published by Transparency Market Research (http://www.transparencymarketresearch.com),"Cervical Cancer Diagnostic Tests (Pap Smear, Colposcopy and ECC Procedures) Market - Global Industry Analysis by Test Type and Age Group, Market Size, Share and Forecast, 2012 - 2018,"the global Pap smear test market was valued atUSD 28.0 millionin 2011 and is expected to reach an estimated value ofUSD 31.4 millionin 2018, growing at a CAGR of 1.7% from 2012 to 2018. Theglobal edocervical curettage (ECC) procedures marketwas valued atUSD 6.7 millionin 2011 and is the fastest growing segment owing to its accuracy during cervical cancer diagnosis.
Browse the full report athttp://www.transparencymarketresearch.com/cervical-cancer-diagnostic-tests-market.html
A high prevalence of HPV-infected patients across the globe, rising incidences of teenage sexual encounters, a rising number of organized cervical cancer programs initiated by governments and NGOs and the rising disposable income of consumers especially in the Asia Pacific region are some of the major growth drivers for the Pap smear tests market. An increasing number of female smokers worldwide and the rising world obesity rate also support the growth of the market.
Government regulations extending the age limit for a Pap smear test in an attempt to curb unnecessary healthcare-related expenditure will restrain the growth of the market to a certain extent. The future of the Pap smear tests market will be fuelled by technological advancements such as the invention of new cytological methods of testing and the rapidly aging population in the U.S., Europe and Japan.
Thecervical cancer diagnostic tests marketis dominated by the U.S. which holds a market share of around 31.3%. In Europe, Germany is the market leader in terms of revenue generated through Pap smear testing. TheAsia Pacific market is expected to exhibit the fastest growth rate during the forecasted period (2012 - 2018).India and China together form the most lucrative segment of the Asia Pacific region owing to their fast growing population coupled with high disposable incomes amongst consum ers and high healthcare-related spending induced by the rapidly developing nature of their economies.
Some of the key players profiled in the report include Guided Therapeutics, Abbott Laboratories, Siemens Healthcare, Ascon Medical Instruments, Olympus, Beckman Coulter Inc, Roche, Cooper Surgical Inc, Cardinal Health and Becton and Dickinson and Company.
Related & Recently Published Reports by Transparency Market Research
Minimally Invasive Surgery Market
Global Osteoporosis Market
Global Nutraceuticals Product Market
Global Nutraceuticals Ingredients Market
Global Surgical Equipment Industry
COPD Drugs Industry
Global Spectrometry Industry
Circulating Tumor Cells Market
Synthetic Biology Industry
U.S. Vaccine Industry
Insulin Devices Market
Home Health Care Industry
This research is specially designed to estimate and analyze the demand and performance of the cervical cancer
diagnostic tests market taking into consideration Pap smear tests, ECC procedures and Colposcopy procedures in a global scenario. The report also provides the number of procedures performed, broken down by age group for each segment of the market. The report covers the market by test steps for cervical cancer diagnostic purpose. The study presents a comprehensive assessment of the stakeholder strategies, winning imperatives for them by segmenting the cervical cancer diagnostic tests market as below:
Cervical Cancer Diagnostic Tests (Pap Smear Tests, Colposcopy and ECC Procedures) Market by Test Types
Pap Smear Tests Abnormal Pap Smear Tests Colposcopy Tests Abnormal Colposcopy Tests ECC Procedures
Cervical Cancer Diagnostic Tests (Pap Smear Tests, Colposcopy and ECC Procedures) Market by Age Group
Age 20 - 40 Age above 40
Cervical Cancer Diagnostic Tests (Pap Smear Tests, Colposcopy and ECC Procedures) Marketby Geography
U.S Europe
Germany U.K France Italy Spain R.O.E (Rest of Europe)
Asia Pacific
Japan China India
Browse allPharmaceuticalMarketResearch Reports
Upcoming Reports inPharmaceuticalMarket
Autologous Cell Therapy Market
Smart Pill Technology Market
Biosimulation Market
Bioinformatics Market
Neuromodulation Devices Market
Hormone Replacement Therapy Market
Agricultural Biotechnology Market
Healthcare Biometrics Market
Acute Myeloid Leukemia (AML) Therapeutics Market
Freeze Drying Equipment Market
About Us
Transparency Market Research is a global market intelligence company, providing global business inform ation reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. We are privileged with highly experienced team of Analysts, Researchers, and Consultants, who use proprietary data sources and various tools and techniques to gather, and analyze information.
Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.
Contact
Sheela AK 90 Sate Street, Suite 700 Albany, NY 12207 Tel: +1-518-618-1030 USA - Canada Toll Free: +1-866-552-3453 e-mail:sales@transparencymarketresearch.com Podcast:http://transparencymarketresearch.podbean.com/ Search Reports:http://www.mrrse.com/